Bioceres Crop Solutions Corp (BIOX) Fair Value & Analysis

Basic Materials · US · Market cap $23.8M · ISIN KYG1117K1141

What is Bioceres Crop Solutions Corp really worth?

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The model range is unusually wide ($0.1542 to $0.7048). The outcome hinges heavily on assumptions, so read the point estimate with caution.
• The price sits close to our fair value, market and models broadly agree here, little valuation tension.
• Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $0.3226 – $16.00 · fair‑value band $0.1542 – $0.7048 · the $0.4192 price screens below the $0.4295 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Bioceres Crop Solutions Corp (BIOX) currently trades at $0.4192, while our model-based Fair Value estimate is $0.4295, implying the stock looks roughly 2.4% fairly valued today. The Quality Score stands at 25/100 (below-average quality), in the Basic Materials sector. Bull case: the Multiples group reads highest at a median of $2.81 per share, and 10 of the 10 models we run sit above the $0.4192 price. Bear case: the Asset-Based group reads lowest at $2.76, and 0 of the 10 models stay below the price. Evidence for this calculation is low.

Over the trailing twelve months, Bioceres Crop Solutions Corp generated revenue of $255M at a net margin of −96.9%. Revenue declined 35.9% year over year. It earns a return on equity of −32.2%. Net debt stands at $244M. Fundamentals as of Aug 13, 2026

Our scenario range runs from $0.1542 (bear case) to $0.7048 (bull case); at $0.4192, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at 9% fair-value upside, at 2%, BIOX screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Widest divergence: Growth DCF ($9.83) versus Asset-Based ($2.76). Highest evidence: FCF DCF (75).

Key figures & financial health

Quality Score breakdown

About the company

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.

Full company description

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Bioceres Crop Solutions Corp reported revenue of $333M in FY2025 versus $207M in FY2021, a compound +12.7%/yr. Reported net income was −$51.8M in FY2025.

Watch BIOX: get an alert when its fair value changes →

Peer Group

Agricultural Inputs · 175 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Agricultural Inputs median · lower = cheaper

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions